Delivery Order SPE2DB22D1017-SPE2DB25FG1AA
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations. This competitively awarded, non-set-aside delivery order carries a ceiling value of $32,930.62 under firm fixed-price terms, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a contract ceiling value of $1,253.32. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 2, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations, with a ceiling value of $8,761.83. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.9 billion through December 2026. The award was made through competitive procedures with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations, with a ceiling value of $5,351.12. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 23, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials, with a ceiling value of $1,566.65. This is a firm fixed-price delivery order with no set-aside designation, placed under competitive award procedures. The contract is set to be completed by September 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml pharmaceutical products, with a ceiling value of $1,566.65. This is a firm fixed price delivery order with an ultimate completion date of April 24, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials, with a contract ceiling value of $31,796.89. This is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and represents a non-set-aside, competitively awarded procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations, valued at $8,976.61. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical...
- The Defense Logistics Agency awarded a $9,656.92 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ozempic (0.25-0.5 mg/dose) pens in 3 ml quantities. The contract represents a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens in 3ml vials, with a contract ceiling value of $4,527.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. This delivery order...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG1AADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations, with a ceiling value of $2,015.92. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is scheduled for ultimate completion by April 25, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement extending through December 2026. This comprehensive contract vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for Ozempic exemplifies the diabetes and metabolic treatment medications within AmerisourceBergen's extensive federal medical supply portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 4/24/25 |